1. Román G, Sotelo J, Del Brutto O, Flisser A, Dumas M, Wadia N, et al. A proposal to declare neurocysticercosis an international reportable disease. Bull World Health Organ. 2000; 78:399–406.
2. Lobato RD, Lamas E, Portillo JM, Roger R, Esparza J, Rivas JJ, et al. Hydrocephalus in cerebral cysticercosis. Pathogenic and therapeutic considerations. J Neurosurg. 1981; 55:786–793.
3. Raccurt CP, Agnamey P, Boncy J, Henrys JH, Totet A. Seroprevalence of human Taenia solium cysticercosis in Haiti. J Helminthol. 2009; 83:113–116.
Article
4. Bouree P, Dumazedier D, Bisaro F, Resende P, Comoy J, Aghakhani N. Spinal cord cysticercosis: a case report. J Egypt Soc Parasitol. 2006; 36:727–736.
5. Monteiro L, Almeida-Pinto J, Stocker A, Sampaio-Silva M. Active neurocysticercosis, parenchymal and extraparenchymal: a study of 38 patients. J Neurol. 1993; 241:15–21.
Article
6. Matushita H, Pinto FC, Cardeal DD, Teixeira MJ. Hydrocephalus in neurocysticercosis. Childs Nerv Syst. 2011; 27:1709–1721.
Article
7. Salazar A, Sotelo J, Martinez H, Escobedo F. Differential diagnosis between ventriculitis and fourth ventricle cyst in neurocysticercosis. J Neurosurg. 1983; 59:660–663.
Article
8. Apuzzo ML, Dobkin WR, Zee CS, Chan JC, Giannotta SL, Weiss MH. Surgical considerations in treatment of intraventricular cysticercosis. An analysis of 45 cases. J Neurosurg. 1984; 60:400–407.
9. Sotelo J, del Brutto OH, Penagos P, Escobedo F, Torres B, Rodriguez-Carbajal J, et al. Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis. J Neurol. 1990; 237:69–72.
Article
10. Ahmad FU, Sharma BS. Treatment of intramedullary spinal cysticercosis: report of 2 cases and review of literature. Surg Neurol. 2007; 67:74–77. discussion 77.
Article
11. Zee CS, Segall HD, Destian S, Ahmadi J, Apuzzo ML. MRI of intraventricular cysticercosis: surgical implications. J Comput Assist Tomogr. 1993; 17:932–939.
12. Mirone G, Cinalli G, Spennato P, Ruggiero C, Aliberti F. Hydrocephalus and spinal cord tumors: a review. Childs Nerv Syst. 2011; 27:1741–1749.
Article
13. Agrawal R, Chauhan SP, Misra V, Singh PA, Gopal NN. Focal spinal intramedullary cysticercosis. Acta Biomed. 2008; 79:39–41.
14. Gardner WJ, Spitler DK, Whitten C. Increased intracranial pressure caused by increased protein content in the cerebrospinal fluid; an explanation of papilledema in certain cases of small intracranial and intraspinal tumors, and in the Guillain-Barre syndrome. N Engl J Med. 1954; 250:932–936.
Article
15. Morandi X, Amlashi SF, Riffaud L. A dynamic theory for hydrocephalus revealing benign intraspinal tumours: tumoural obstruction of the spinal subarachnoid space reduces total CSF compartment compliance. Med Hypotheses. 2006; 67:79–81.
Article
16. Raksin PB, Alperin N, Sivaramakrishnan A, Surapaneni S, Lichtor T. Noninvasive intracranial compliance and pressure based on dynamic magnetic resonance imaging of blood flow and cerebrospinal fluid flow: review of principles, implementation, and other noninvasive approaches. Neurosurg Focus. 2003; 14:e4.
Article
17. Garcia HH, Rodriguez S, Gilman RH, Gonzalez AE, Tsang VC. Cysticercosis Working Group in Peru. Neurocysticercosis: is serology useful in the absence of brain imaging? Trop Med Int Health. 2012; 17:1014–1018.
Article